Bulletin of Mathematical BiologySystems BiologyPeer-reviewed journal article
Comparison of drug inhibitory effects (IC50) in monolayer and spheroid cultures
Catherine Berrouët, Naika Dorilas, Katarzyna Anna RejniakiD, Necibe TunceriD
Abstract
Traditionally, the monolayer (two-dimensional) cell cultures are used for initial evaluation of the ef-fectiveness of anticancer drugs. In particular, these experiments provide the IC50 curves that determine drug concentration that can inhibit growth of a tumor colony by half when compared to the cells grown with no exposure to the drug. Low IC50 value means that the drug is effective at low concentrations, and thus will show lower systemic toxicity when administered to the patient. However, in these experiments cells are grown in a monolayer, all well exposed to the drug, while in vivo tumors expand as three-dimensional multicellular masses, where inner cells have a limited access to the drug. Therefore, we performed computational studies to compare the IC50 curves for cells grown as a two-dimensional monolayer and a cross section through a three-dimensional spheroid. Our results identified conditions (drug diffusivity, drug action mechanisms and cell proliferation capabilities) under which these IC50 curves differ significantly. This will help experimentalists to better determine drug dosage for future in vivo experiments and clinical trials.
- Citations
- 133
- FWCI
- 1.59
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles
T. R. Tidwell, G. Rosland, … H. R. Hagland·bioRxiv·Nov 22, 2023
- Cell line-dependent effects of spheroid formation method on drug response in melanoma models
Akvilė Žilytė, Vilma Petrikaitė·CellsPeer-reviewed·Jun 11, 2026
- Precise, high-throughput production of multicellular spheroids with a bespoke 3D bioprinter
R. H. Utama, L. Atapattu, … J. Gooding·bioRxiv·Apr 6, 2020
- Sophorolipid Candidates Demonstrate Cytotoxic Efficacy Against 2D and 3D Breast Cancer Models
C. L. Roberge, R. T. Miceli, … D. T. Corr·bioRxiv·Sep 1, 2022
- VITAL-3D: Volumetric Single-Cell Quantification Reveals Microenvironment-Dependent Drug Responses in Breast Cancer
Chongguang Jin, Tiffany Chu, … Pei-Hsun Wu·bioRxiv·Sep 2, 2026
- Kinetics and efficacy of antibody drug conjugates in 3D tumour models
C. S. P. Chaundler, H. Lu, … S. Ghaem-Maghami·bioRxiv·Feb 14, 2023